US Broker Ratings

GeneDx Holdings Corp. (WGS) Stock Analysis: Strong Buy Ratings and 20% Potential Upside

Investors looking for opportunities in the healthcare sector should take a close look at GeneDx Holdings Corp. (WGS), a company making significant strides in the genomics..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook on a Promising Biotech with 87% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company at the forefront of developing treatments for serious and rare diseases, has caught the attention of investors with..

Astrana Health Inc. (ASTH) Stock Analysis: Poised for Growth with 37% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is capturing the attention of investors with its impressive revenue growth and significant potential..

SS Innovations International (SSII) Stock Analysis: Unveiling a 77% Upside Potential in the Thriving Surgical Robotics Market

SS Innovations International, Inc. (SSII) stands as a noteworthy contender in the healthcare sector, specifically within the burgeoning medical devices industry. With its headquarters in Gurugram,..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating Challenges with a 1.63% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a notable player in the healthcare sector, specifically within the health information services industry. Based in the United States,..

10x Genomics, Inc. (TXG)

⚠️ No article content returned.

..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unveiling a 37% Potential Upside for Savvy Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry, stands out in the..

Travere Therapeutics, Inc. (TVTX): Growth Potential in Rare Disease Market with Strong Buy Ratings

Travere Therapeutics, Inc. (NASDAQ: TVTX) is emerging as a noteworthy player in the biotechnology sector, with its focus on developing therapies for rare kidney and metabolic..

Neogen Corporation (NEOG) Stock Analysis: Is the Healthcare Innovator’s 9.24% Upside Within Reach?

Investors with a keen eye on the healthcare sector may find Neogen Corporation (NASDAQ: NEOG) an intriguing prospect. As a key player in the medical devices..

Arcutis Biotherapeutics, Inc. (ARQT): Investor Outlook on a Potential 33% Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a rising star in the biotechnology sector, is capturing investor attention with its strong revenue growth and promising market prospects. Headquartered..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook Reveals 8.80% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 28.66% Potential Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology industry, offers a compelling investment opportunity amidst the dynamic healthcare sector. With a market capitalization..

Sotera Health Company (SHC) Stock Analysis: Evaluating a 13.64% Potential Upside and Strong Buy Ratings

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Unpacking a 40% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biotech sector with its focus on developing therapies for rare and debilitating diseases. With a market..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Significant Upside Potential with 138% Growth Prospects

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its promising growth potential in the healthcare sector. Headquartered in Durham, North Carolina, BioCryst..

MiMedx Group, Inc (MDXG) Stock Analysis: Unpacking a 54% Potential Upside in Biotech

MiMedx Group, Inc. (NASDAQ: MDXG) stands as a compelling figure in the biotech sector, boasting a market capitalization of $622.4 million. Specializing in the development and..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: What Investors Need to Know About Its 44.7% Revenue Growth

Investors have shown increasing interest in Establishment Labs Holdings Inc (NASDAQ: ESTA) as the company continues to make waves in the healthcare sector, particularly within the..

IDEAYA Biosciences (IDYA) Stock Analysis: Unpacking a 51% Potential Upside with Strong Buy Ratings

IDEAYA Biosciences, Inc. (IDYA), a prominent player in the biotechnology sector, is capturing investor attention with its innovative precision medicine oncology solutions and a robust market..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering a 16.68% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) presents an intriguing opportunity for investors with its focus on groundbreaking therapies for autoimmune diseases. Based in Edmonton, Canada, this biopharmaceutical..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A 43.66% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has captured investor attention with its promising growth prospects and a substantial potential upside...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds